Cargando…

Living donor liver transplantation can address disparities in transplant access for patients with primary sclerosing cholangitis

BACKGROUND: Liver transplantation (LT) is frequently lifesaving for people living with primary sclerosing cholangitis (PSC). However, patients are waitlisted for LT according to the model for end-stage liver disease-sodium (MELD-Na) score, which may not accurately reflect the burden of living with P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Onofrio, Fernanda, Zheng, Katina, Xu, Cherry, Chen, Shiyi, Xu, Wei, Vyas, Mary, Bingham, Katie, Patel, Keyur, Lilly, Leslie, Cattral, Mark, Selzner, Nazia, Jaeckel, Elmar, Tsien, Cynthia, Gulamhusein, Aliya, Hirschfield, Gideon M., Bhat, Mamatha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552969/ https://www.ncbi.nlm.nih.gov/pubmed/37534935 http://dx.doi.org/10.1097/HC9.0000000000000219

Ejemplares similares

A42 LIVE DONOR LIVER TRANSPLANTATION IN PRIMARY SCLEROSING CHOLANGITIS: AN INDICATOR OF AN ORGAN ALLOCATION SYSTEM NOT ADDRESSING PATIENT NEED
por: Zheng, K, et al.
Publicado: (2023)

Availability of living donor optimizes timing of liver transplant in high-risk waitlisted cirrhosis patients
por: Arisar, Fakhar Ali Qazi, et al.
Publicado: (2023)

A210 HEPATOLITHIASIS IS A FREQUENT AND PROGNOSTIC FINDING IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS
por: Jubran, B, et al.
Publicado: (2022)

Primary Sclerosing Cholangitis: Palliative Surgery or Transplantation?
por: Cameron, John L.
Publicado: (1992)

Transplantation for Primary Sclerosing Cholangitis: Outcomes and Recurrence
por: Saner, Fuat H., et al.
Publicado: (2023)

Early Allograft Dysfunction After Liver Transplantation With Donation After Circulatory Death and Brain Death Grafts: Does the Donor Type Matter?
por: Mazilescu, Laura Ioana, et al.
Publicado: (2021)

Renal Dysfunction After Liver Transplantation: Effect of Donor Type
por: Kollmann, Dagmar, et al.
Publicado: (2020)

Single-Center North American Experience of Liver Transplantation in Autoimmune Hepatitis: Infrequent Indication but Good Outcomes for Patients
por: de Quadros Onofrio, Fernanda, et al.
Publicado: (2020)

Liver transplantation for post-COVID-19 sclerosing cholangitis
por: Lee, Angela, et al.
Publicado: (2021)

Expanding the donor pool: Donation after circulatory death and living liver donation do not compromise the results of liver transplantation
por: Kollmann, Dagmar, et al.
Publicado: (2018)

Secondary sclerosing cholangitis: mimics of primary sclerosing cholangitis
por: Ludwig, Daniel R., et al.
Publicado: (2022)

Early Intervention With Live Donor Liver Transplantation Reduces Resource Utilization in NASH: The Toronto Experience
por: Barbas, Andrew S., et al.
Publicado: (2017)

Autotaxin activity predicts transplant-free survival in primary sclerosing cholangitis
por: Dhillon, Amandeep K., et al.
Publicado: (2019)

Indications and Outcomes in Liver Transplantation in Patients With Primary Sclerosing Cholangitis in Norway
por: Andersen, Ina M., et al.
Publicado: (2015)

LIVER TRANSPLANTATION IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS: A MULTICENTRIC STUDY
por: Wiederkehr, Henrique de Aguiar, et al.
Publicado: (2023)

Liver transplant in primary sclerosing cholangitis: Current trends and future directions
por: Shah, Yash R, et al.
Publicado: (2023)

Living-Donor Liver Transplant and Improved Post-Transplant Survival in Patients with Primary Sclerosing Cholangitis
por: Sierra, Leandro, et al.
Publicado: (2023)

Should We Exclude Live Donor Liver Transplantation for Liver Transplant Recipients Requiring Mechanical Ventilation and Intensive Care Unit Care?
por: Goldaracena, Nicolas, et al.
Publicado: (2015)

Intrahepatic macrophage populations in the pathophysiology of primary sclerosing cholangitis
por: Chen, Yung-Yi, et al.
Publicado: (2019)

Real‐World Effectiveness of Obeticholic Acid in Patients with Primary Biliary Cholangitis
por: Roberts, Surain B., et al.
Publicado: (2020)

Recurrence of primary sclerosing cholangitis after liver transplantation – analysing the European Liver Transplant Registry and beyond
por: Visseren, Thijmen, et al.
Publicado: (2021)

Suspicious brush cytology is an indication for liver transplantation evaluation in primary sclerosing cholangitis
por: Boyd, Sonja, et al.
Publicado: (2017)

Efficacy of oral vancomycin in recurrent primary sclerosing cholangitis following liver transplantation
por: Hey, Penelope, et al.
Publicado: (2017)

A novel prognostic model for transplant-free survival in primary sclerosing cholangitis
por: de Vries, Elisabeth M, et al.
Publicado: (2018)

Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)—A European Society of Organ Transplantation (ESOT) Consensus Statement
por: Carbone, M., et al.
Publicado: (2023)

IgG4-Related Sclerosing Cholangitis and Primary Sclerosing Cholangitis
por: Tanaka, Atsushi
Publicado: (2019)

Primary Sclerosing Cholangitis With Features of Autoimmune Hepatitis: Exploring the Global Variation in Management
por: Milkiewicz, Piotr, et al.
Publicado: (2020)

Primary sclerosing cholangitis.
por: Spence, R. A., et al.
Publicado: (1984)

Primary sclerosing cholangitis
por: Worthington, Joy, et al.
Publicado: (2006)

Healthy Donor Fecal Microbiota Transplantation for Recurrent Bacterial Cholangitis in Primary Sclerosing Cholangitis – A Single Case Report
por: Philips, Cyriac Abby, et al.
Publicado: (2018)

Biliary microbial patterns in primary sclerosing cholangitis are linked to poorer transplant-free survival
por: Özdirik, Burcin, et al.
Publicado: (2023)

Methylation signatures in peripheral blood are associated with marked age acceleration and disease progression in patients with primary sclerosing cholangitis
por: Trauner, Michael, et al.
Publicado: (2019)

Successful Treatment of Recurrent Primary Sclerosing Cholangitis after Orthotopic Liver Transplantation with Oral Vancomycin
por: Davies, Yinka K., et al.
Publicado: (2013)

Primary sclerosing cholangitis associated colitis: Characterization of clinical, histologic features, and their associations with liver transplantation
por: Aranake-Chrisinger, John, et al.
Publicado: (2020)

Circulating Macrophage Activation Markers Predict Transplant-Free Survival in Patients With Primary Sclerosing Cholangitis
por: Bossen, Lars, et al.
Publicado: (2021)

Meta-analysis and systematic review of liver transplantation as an ultimate treatment option for secondary sclerosing cholangitis
por: Gadour, Eyad, et al.
Publicado: (2021)

Comprehensive Complication Index to Monitor Morbidity and Mortality After Liver Transplantation in Primary Sclerosing Cholangitis
por: Vannas, Marko J., et al.
Publicado: (2023)

Liver transplant in patients with primary sclerosing cholangitis: A retrospective cohort from Northeastern Brazil
por: Freitas, Louyse Teixeira de Souza, et al.
Publicado: (2023)

Liver transplantation in adult polycystic liver disease: the Ontario experience
por: Alsager, Mohammed, et al.
Publicado: (2021)

The immunobiology of primary sclerosing cholangitis
por: Aron, Jonathan H., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_egma7kdm96tdevdd2lsmet4osp